Ribonucleoside vanadyl complexes
Based on 1 Customer Validation
Ribonucleoside vanadyl complexes are a class of potent RNase and Taq polymerase inhibitors. Ribonucleoside vanadyl complexes protect RNA during RNA isolation by inhibiting ribonucleases, and also reduce the viability of bacteria and eukaryotic cells by interfering with ribosomal subunit assembly. Ribonucleoside vanadyl complexes block PCR and reverse transcription reactions templated by viral nucleic acids and enhance the effects of antibiotics against Staphylococcus aureus, but do not directly inhibit protein synthesis. Ribonucleoside vanadyl complexes can be effectively removed by phenol-chloroform extraction, thus enabling subsequent PCR analysis. Ribonucleoside vanadyl complexes can be applied in research related to chronic hepatitis C (HCV) and Staphylococcus aureus infection.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示
More
生物活性
Ribonucleoside vanadyl complexes (RVC) (0.04-8 mM) potently inhibit PCR reactions using both HCV cDNA and HBV DNA templates, with consistent inhibition observed at concentrations of 0.4 mM and higher, while 0.04 mM has no inhibitory effect[1].
Ribonucleoside vanadyl complexes (RVC) (20 mM; 4-5 days) inhibits RT-nPCR detection of HCV RNA, even when positive HCV RNA is spiked into the reaction, when included during prolonged proteinase K digestion of formalin-fixed paraffin-embedded liver tissue[1].
Ribonucleoside vanadyl complexes (5 mM) reduced the viable cell counts of methicillin-resistant (HY-121544) MSSA RN1786 and MRSA A1024 by >90%[2].
Ribonucleoside vanadyl complexes (5 mM) reduces ribosomal subunit formation by 90%, reduces 50S subunit relative abundance by ~15% in MSSA cells, and increases rRNA degradation in both MSSA RN1786 and MRSA A1024 cells[2].
Ribonucleoside vanadyl complexes (5 mM) reduces the synthesis rate of both 30S and 50S ribosomal subunits, including a 4-fold reduction in 50S subunit synthesis, in MSSA RN1786 and MRSA A1024 cells[2].
Ribonucleoside vanadyl complexes (1-5 mM; ~34 h) reduce viable cell counts by ~90%-98% in RAW 264.7 macrophage and BJ fibroblast cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Methicillin-susceptible Staphylococcus aureus (MSSA) RN1786, methicillin-resistant Staphylococcus aureus (MRSA) A1024
-
Concentration:5 mM
-
Incubation Time:matched growth period for viability assessment (added after 1 h initial growth)
-
Result:Decreased cell viability by >90% in both MSSA and MRSA strains.
Reduced MSSA cfu to 11×107/mL (5.3% of control) and MRSA cfu to 5×107/mL (1.6% of control), with statistically significant differences from untreated cells.
-
Cell Line:RAW 264.7 macrophage, BJ fibroblast
-
Concentration:0.5 mM, 1 mM, 5 mM
-
Incubation Time:~34 h total post-addition (added after 2 h initial growth for macrophages or 12 h initial growth for fibroblasts)
-
Result:Reduced viable cell number by ~90%-98% in both macrophage and fibroblast cultures at 1 mM and 5 mM concentrations.
化学情報
-
性状 Liquid
-
Color Dark blue to black
-
SMILES
[Ribonucleoside vanadyl complexes]
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
-
データシート (269 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Ribonucleoside vanadyl complexes 関連分類
HY-E70529 関連分類
Powered by Bioz